$0.64
+0.04 (+7.52%)
Open$0.64
Previous Close$0.59
Day High$0.64
Day Low$0.59
52W High$3.16
52W Low$0.48
Volume—
Avg Volume2.0K
Market Cap2.75M
P/E Ratio—
EPS$-2.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+454.9% upside
Current
$0.64
$0.64
Target
$3.54
$3.54
$2.21
$3.54 avg
$4.26
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 99.26M | 85.10M | 4.60M |
| Net Income | -19,446,601 | -15,005,093 | 612.3K |
| Profit Margin | -19.6% | -18.6% | 13.3% |
| EBITDA | -17,318,861 | -14,105,725 | 960.1K |
| Free Cash Flow | — | — | 405.9K |
| Rev Growth | +16.6% | +16.6% | +11.5% |
| Debt/Equity | 3.44 | 3.44 | 0.89 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |